Aquestive Therapeutics Inc (AQST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Sales | 13,206 | 13,002 | 13,241 | 11,134 | 10,682 |
| Cost of Goods | 4,679 | 4,798 | 6,617 | 4,737 | 5,305 |
| Gross Profit | 8,527 | 8,204 | 6,624 | 6,397 | 5,377 |
| Operating Expenses | 13,117 | 11,379 | 11,450 | 11,739 | 16,395 |
| Operating Income | -3,911 | -2,377 | -4,209 | -4,605 | -10,713 |
| Interest Expense | 3,235 | 1,312 | 1,428 | 1,487 | 1,704 |
| Other Income | -864 | 1,514 | 129 | 14,160 | 65 |
| Pre-tax Income | -8,010 | -2,175 | -5,508 | 8,068 | -12,352 |
| Income Tax | 101 | -140 | 284 | N/A | N/A |
| Net Income Continuous | -8,111 | -2,035 | -5,792 | 8,068 | -12,352 |
| Net Income | $-8,111 | $-2,035 | $-5,792 | $8,068 | $-12,352 |
| EPS Basic Total Ops | -0.15 | -0.03 | -0.10 | 0.15 | -0.21 |
| EPS Basic Continuous Ops | -0.14 | -0.03 | -0.10 | 0.15 | -0.20 |
| EPS Diluted Total Ops | -0.11 | -0.03 | -0.10 | 0.11 | -0.21 |
| EPS Diluted Continuous Ops | -0.11 | -0.03 | -0.10 | 0.11 | -0.20 |
| EBITDA(a) | $-1,646 | $-2,054 | $-3,861 | $-4,224 | $-10,258 |